Biotech firm Ascletis Pharma said ASC47, its muscle-preserving weight loss drug candidate, could boost the efficacy of the ...

The new tariffs, effective 1 October, are also aimed at kitchen cabinets, bathroom vanities & heavy trucks. Any levies on ...

Experts in Europe are concerned about what the global GLP-1 agonist excitement could mean for childhood obesity, which can ...

Pfizer said on Monday it would acquire drug developer Metsera in a deal valued at up to $7.3 billion, including future ...

UK shoppers are the most budget-conscious in the world when it comes to wellness, says Alex Heffernan, insight manager for ...

Weight management drugs like the GLP-1 can significantly improve health outcomes, but their exorbitant prices often limit ...

"The findings are very exciting,” said Dr. Prachi Singh at Pennington Biomedical. “This supports the growing understanding ...

Millions of Americans who could benefit from GLP-1 weight-loss drugs are caught in the middle of a battle between drug ...

New research unveils a groundbreaking quintuple agonist that targets multiple pathways for effective treatment of obesity and ...

Ozempic, marketed by Novo Nordisk in India, is primarily indicated for the treatment of type 2 diabetes. While it can lead to ...

The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at ...

So welcome to our Pharma Day 2025 here in London. It's good to see here full house. I was told we have, I think, a record attendance here on site, and we also have quite a high number, I think, of web ...